| The Biological Variation of Testosterone and Sex Hormone-Binding Globulin (SHBG) in Polycystic Ovarian Syndrome: Implications for SHBG as a Surrogate Marker of Insulin Resistance, Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA and Atkin SL, 2003, J Clin Endocrinol Metab, 88(4), 1528-33 | 4.3 | 94.7 | Females | Healthy (excl pregnant) | Serum |
| Within-and between-subjet biological variations of follitropin, lutropin, testesterone, and sex-binding globulin in men, Valero-Politi J, Fuentes-Arderiu X, 1993, Clin Chem, 39, 1723-5 | 12.1 | 42.7 | Males | Healthy (excl pregnant) | Serum |
| Variation in levels of serum Inhibin B, testosterone, estradiol, luteinizing hormone, follicle-stimulating hormone and sex hormone binding globulin in monthly samples from healthy men during a 17-month period: possible effects of seasons, Andersson AM, Carlsen E, Petersen JH and Skakkebaek NE, 2003, J Clin Endocrinol Metab, 88, 932-937 | 14.0 | 30.0 | Males | Healthy (excl pregnant) | Serum |
| The significance of biological variation in the diagnosis of testosterone deficiency, and consideration of the relevance of total, free and bioavailable testosterone determinations, Collier CP, Morales A, Clark A, Lam M, Wynne-Edwards K and Black A, 2010, J Urol, 183, 2294-9 | 11.3 | 33.7 | Males | Healthy (excl pregnant) | Unknown |
| The significance of biological variation in the diagnosis of testosterone deficiency, and consideration of the relevance of total, free and bioavailable testosterone determinations, Collier CP, Morales A, Clark A, Lam M, Wynne-Edwards K and Black A, 2010, J Urol, 183, 2294-9 | 9.1 | 34.1 | Males | Healthy (excl pregnant) | Unknown |
| The significance of biological variation in the diagnosis of testosterone deficiency, and consideration of the relevance of total, free and bioavailable testosterone determinations, Collier CP, Morales A, Clark A, Lam M, Wynne-Edwards K and Black A, 2010, J Urol, 183, 2294-9 | 5.4 | 34.6 | Males | Healthy (excl pregnant) | Unknown |
| The Biological Variation of Testosterone and Sex Hormone-Binding Globulin (SHBG) in Polycystic Ovarian Syndrome: Implications for SHBG as a Surrogate Marker of Insulin Resistance, Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA and Atkin SL, 2003, J Clin Endocrinol Metab, 88(4), 1528-33 | 19.4 | 79.3 | Females | Non-healthy (excl pregnant) | Serum |
